Vivior heeft financieringsronde met particuliere investeerders uit Europa en de VS gesloten
ZURICH—(BUSINESS WIRE)– Cataract, de vertroebeling van de lens in het oog, treft wereldwijd meer dan 50 miljoen mensen per jaar. De standaardbehandeling bestaat uit het implanteren van een kunstmatige intraoculaire lens (IOL). Oogheelkundige chirurgen vertrouwen op dit moment op subjectieve patiënteninterviews bij het selecteren van de kracht en het type van de IOL, wat kan leiden tot onbevredigende patiënt resultaten als deze keuze niet nauwkeurig of gepast is.
Dit persbericht is multimediaal. Bekijk de volledige versie hier: https://www.businesswire.com/news/home/20180712005357/en/
Een nieuw draagbaar systeem verzamelt dagelijkse activiteitsgegevens van patiënten, verwerkt deze gegevens in de cloud en analyseert de levensstijlpatronen van patiënten met behulp van algoritmen voor machine-learning.
Vivior Closed Financing Round with Private Investors from Europe and The US
ZURICH–(BUSINESS WIRE)– Cataract, the clouding of the lens in the eye, affects over 50 million people per year world-wide. The standard treatment consists of implanting an artificial intraocular lens (IOL). Ophthalmic surgeons currently rely on subjective patient interviews when selecting the power and type of the IOL, which can lead to unsatisfactory patient outcomes if this choice is not accurate or appropriate.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180712005357/en/
Wearable device to track visual behavior (Photo: Business Wire)
A novel wearable system collects daily activity data from patients, processes these data in the cloud and analyses patient’s lifestyle patterns using machine-learning algorithms. This combination of data enables surgeons to offer optimal personalized solutions to their patients leading to active patient engagement and increased patient satisfaction.
According to Arthur Cumming MD, eye surgeon at the Wellington Eye Clinic and former President of the American European Congress of Ophthalmic Surgery, “we will look back in 5 years’ time and wonder how we ever managed to treat patients without objective data”.
Vance Thompson MD, Professor of Ophthalmology at the Sanford School of Medicine, Sioux Falls, South Dakota, USA, adds “I want to use the system every day to help educate patients on how they use their vision. Understanding the exact distances and how much time spent at each distance will help them choose the best premium implant for their life long vision decision.”
Vivior has recently closed an investment round with private investors from Europe and the US. With multiple million USD raised, it will finalize the currently running clinical study to assess the usability of their system and measure market acceptance. Based on these results, Vivior will register the system in Europe and the US to make it available to clinics, surgeons and patients.
About Vivior:
Vivior is a Swiss digital health start-up founded in 2017 by a group of experienced eye care professionals. Its ground-breaking combination of a wearable device and machine-learning algorithms allows it to track the visual needs of patients in their daily life. The data is analyzed in the cloud and made available to health care professionals to better understand patients’ needs.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005357/en/
Contacts
Vivior AG
Mario Stark
CEO
mario.stark@vivior.com
+41 79 542 88 74